RE:Bryan GarnierStockMarketBull wrote: Aphria (TSX:APH) Bryan Garnier starts coverage with a "buy" and a price target of $31 (Canadian), saying the company is well placed to take advantage of the global trend to legalize medical and/or recreational cannabis.
It does appear that the $31 price tag is purely based on the current business results, neither Diageo nor Altria !!! https://www.theglobeandmail.com/investing/markets/inside-the-market/article-fridays-analyst-upgrades-and-downgrades-28/